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Dr Hartwigdoi:10.1016/j.jtcvs.2005.06.054Objective: Emerging clinical evidence suggests that gastroesophageal reflux disease
is associated with pulmonary allograft dysfunction. In this study, we used a model
of rat lung transplantation to test the hypothesis that chronic aspiration of gastric
contents accelerates pulmonary allograft dysfunction.
Methods: We evaluated the effects of chronic aspiration on pulmonary isografts
(strain F344) and pulmonary allografts (strain WKY to strain F344). Chronic
aspiration consisted of 0.5 mL/kg of filtered gastric contents injected weekly into the
left lung for 4 to 8 weeks beginning 1 week after transplantation. Seven days after
the last aspiration, animals were killed, and grafts were evaluated grossly and by
histologic and immunochemical analyses, including Masson trichrome staining for
collagen and immunostaining for CD68 and CD8 cells. Serum cytokine concen-
trations were determined by bead-based immunoassays or enzyme-linked immu-
nosorbent assay.
Results: Allografts without aspiration (n  12) demonstrated a relatively normal
architecture with diffuse International Society for Heart and Lung Transplantation
grade 3 acute rejection; occasional grade 4 rejection was noted. In contrast, allo-
grafts with chronic aspiration (n  7) demonstrated severe grade 4 acute rejection
with significant monocyte infiltration, fibrosis, and loss of normal alveolar anatomy.
Grossly, 8 (67%) of 12 allografts without aspiration seemed to inflate and perfuse
normally, whereas all allografts exposed to chronic aspiration were firm and
shrunken, without the ability to ventilate (P  .013; Fisher exact test). Aspiration
was associated with increases in graft-infiltrating macrophages and CD8 T cells
and higher levels of serum transforming growth factor .
Conclusions: Chronic aspiration of gastric contents promotes accelerated allograft
failure and may promote a profibrotic environment.
Lung transplantation represents a viable option for improving the quality oflife and extending the survival of end-stage lung disease patients. Theprimary limiting factor in long-term survival for lung transplant recipients
remains bronchiolitis obliterans (OB).1 OB is a pathologic lesion characterized by
luminal compromise of small airways by eosinophilic plaques and collagen depo-
sition, but it is very challenging to diagnose by transbronchial biopsy.2 Because of
the difficulty with diagnosis, a clinical correlate for OB was developed and is known
as bronchiolitis obliterans syndrome, or BOS.3 The most important predictor of
BOS development is the frequency and severity of acute rejection episodes; how-
ever, medical noncompliance, HLA mismatching, and infection may also play a
role.4-7
A growing number of studies associate gastroesophageal reflux disease (GERD)
with various pulmonary pathologies, including interstitial pulmonary fibrosis,8
chronic bronchitis,9 and asthma.10 Also, there is some indication that patients with
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pulmonary symptoms after surgical correction of reflux.11
More recently, mounting clinical evidence suggests a strong
relationship between GERD and allograft dysfunction in
lung transplant recipients. A review of our lung transplant
registry revealed that recipients with abnormally increased
esophageal acid contact times experienced impaired pulmo-
nary function and decreased survival,12 as well as higher
rates of acute rejection.13 Additionally, fundoplication
seemed to ameliorate the deleterious effects of GERD in
these patients.12-14
Although these data are compelling, the detailed mech-
anisms of GERD’s role in the development of BOS remain
to be elucidated. It is possible that abnormally prolonged
esophageal exposure to gastroduodenal contents predisposes
recipients to chronic microaspiration and occasional mac-
roaspiration. Preliminary data from other centers demonstrate
that bile acids and pepsin are present in high concentrations
in the bronchoalveolar lavage fluid of lung transplant recip-
ients; this suggests that tracheobronchial exposure to enteric
contents may be occurring.15,16 Repetitive aspiration events
occurring in a denervated pulmonary allograft lacking nor-
mal cough and mucociliary reflexes would lead to longer
contact with respiratory epithelium and, potentially, an aug-
mented injury pattern. The mode of injury likely includes
direct toxicity by aspirated enteric contents, but may also
involve stimulation of innate and adaptive immunity sys-
tems. In this study, a rodent model of repetitive, controlled
aspiration in the setting of lung transplantation was devel-
oped to elucidate the mechanisms underlying aspiration-
induced injury to pulmonary allografts.
Materials and Methods
Animals
Inbred male Wistar-Kyoto (WKY; haplotype RT1l) and Fischer
F344 (F344; haplotype RT1lv1) rats were obtained from Harlan
Sprague-Dawley (Indianapolis, Ind). Rats weighing 225 to 275 g
were used for all experiments. Animals were housed in a pathogen-
free environment in accordance with institutional guidelines. Ex-
Abbreviations and Acronyms
APC  antigen-presenting cell
BOS  bronchiolitis obliterans syndrome
F344  Fischer F344
GERD gastroesophageal reflux disease
IL  interleukin
OB  bronchiolitis obliterans
PA  pulmonary artery
PV  pulmonary vein
TGF  transforming growth factor
WKY Wistar-Kyotoperiments and animal care were approved by the Duke University
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Animal Welfare Act and were in compliance with the Guide for
the Care and Use of Laboratory Animals.
Transplantation
Left lungs from either WKY or F344 rats were orthotopically
transplanted into F344 rats via a nonsuturing external cuff tech-
nique similar to that described by Mizobuchi and colleagues.17
Briefly, the donor was anesthetized with inhaled isoflurane (2%-
3%) and then administered pentobarbital (50 mg/kg) intraperito-
neally. The donor was then ventilated via a tracheotomy (80
breaths per minute; tidal volume of 7 mL/kg), and a midline
sternolaparotomy was performed. The animal was heparinized
with heparin (2 U/g) delivered intravenously before flushing of
the pulmonary artery (PA) with 25 mL of Celsior preservation
solution (SangStat, Fremont, Calif) at 4°C. The heart-lung
block was then removed, and the left lung was isolated and
separated. After procurement, the left pulmonary vein (PV),
PA, and main bronchus were passed through polytetrafluoro-
ethylene cuffs, everted over the cuffs, and then secured with 5-0
silk suture. A 16-gauge cuff was used for the PA, whereas the
PV and main bronchus required 14-gauge cuffs. After cuff
placement, the donor graft was wrapped in Celsior-soaked gauze and
placed on ice.
The recipient rodent was sedated with ketamine (40 mg/kg) and
atropine (0.01 mg/kg) and then orotracheally intubated with a
14-gauge intravenous catheter. The recipient was anesthetized with
isoflurane (2%-3%) during the procedure and ventilated at a rate of
80 breaths per minute and a tidal volume of 7 mL/kg. A left
thoracotomy was made in the third intercostal space, followed by
dissection of the left lung hilum. The left PV, PA, and main
bronchus were then isolated and occluded with microaneurysm
clamps (Mizuho America, Beverly, Mass), and small incisions
were made anteriorly for subsequent insertion of each respective
cuff. After insertion, the cuffs were secured by using 5-0 silk
suture, and ventilation and perfusion were reestablished by remov-
ing the hilar clamps. The chest was closed in 3 layers, and a pleural
drainage tube was maintained until the recipient recovered from
anesthesia. No immunosuppression was used in any recipient.
Repetitive Aspiration
Gastric fluid was collected from rodents by using the following
procedure: a small midline incision was made over the upper
abdomen, and the peritoneal cavity was entered. The stomach and
proximal duodenum were dissected free. The proximal duodenum
was then ligated with 2-0 silk suture, and a small gastrostomy was
created through which a gastrostomy tube was inserted. The gas-
trostomy tube was placed to gravity drainage and the gastric fluid
was collected in a 50-mL sterile conical tube. The gastric fluid was
then filtered through a 70-m strainer (BD Biosciences, Bedford,
Mass) to remove particulate matter, pooled, and frozen for future
aspiration experiments. The gastric fluid pH was 2 to 2.5 just
before intratracheal instillation.
Each recipient in the aspiration arm of the experiment began
receiving once-weekly gastric fluid instillation into the left lung 1
week after transplantation. To accomplish this, each recipient was
sedated and orotracheally intubated with a 16-gauge intravenous
catheter. The subject was then placed with the head directed
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A small silicone rubber catheter was inserted into the distal trachea
through which 0.5 mL/kg of gastric fluid was injected into the left
lung. The small silicone rubber catheter and the endotracheal tube
were then flushed clear with air. Experiments were terminated, and
animals were killed 5 or 9 weeks after transplantation—1 week
after the final aspiration event.
On the basis of previous work in the field of aspiration pneu-
monitis, in addition to unpublished preliminary experiments in our
laboratory, the dose of aspirated material was determined to be
approximately 10% to 50% of a potentially lethal bolus of gastric
secretions.18,19 This dose of gastric fluid was initially selected to
avoid early mortality as a result of aspiration. In our preliminary
experiments, we experienced no mortality as a direct result of the
aspiration event. Images of rat lungs containing various amounts
(0-0.5 mL) of aspirated contrast material were quantitatively as-
sessed by using the program Scion Image (Scion Corporation,
Frederick, Md). A linear relationship (r  0.99) between image
density and aspirated material was obtained for the left lung,
whereas no increase in image density was observed in the right
(untreated) lungs of the same rats. With this method, approxi-
mately 99% of instilled contrast administered in this manner
selectively enters the left lung (data not shown).
Histology
Lung tissue was fixed by using 2% paraformaldehyde. Left and
right lung biopsy specimens were stained with hematoxylin and
eosin as well as Masson trichrome stains. The extent of fibrosis in
trichrome-stained specimens was graded by a single pathologist in
a blinded fashion by using a continuous numeric scale in which the
overall severity of interstitial fibrosis was determined on a scale of
0 (normal lung) to 8 (total fibrous obliteration), as described
elsewhere.20 Immunohistochemical analysis was performed with
anti-rat CD68 and CD8 monoclonal antibodies (Becton Dickinson,
Franklin Lakes, NJ). Anti-rat CD68 recognizes a single-chain
glycoprotein of 110 kd that is expressed predominantly on the
lysosomal membrane of myeloid cells. Weak cell-surface expres-
sion also occurs. The antigen is expressed by most tissue macro-
phages and is expressed weakly by peripheral blood granulo-
cytes.21 Anti-rat CD8 recognizes the rat CD8 cell-surface antigen
expressed by a subset of T lymphocytes, most thymocytes, and
most natural killer cells.22
Cytokine Assays
Serum specimens were thawed and cytokine concentrations of inter-
leukin (IL)-2, IL-4, IL-6, IL-10, and tumor necrosis factor  were
measured by using Bio-Plex multiplex bead-based immunoassays
(Bio-Rad Laboratories, Hercules, Calif). Specimens were analyzed by
using a Luminex 100 flow-based, dual-laser array reader (Luminex,
Austin, Tex), and cytokine concentrations were quantified by using
Bio-Plex Manager Software (Bio-Rad Laboratories). The concentra-
tion of transforming growth factor (TGF)-1 was determined from
samples by using an enzyme-linked immunosorbent assay–based
sandwich immunoassay (R&D Systems, Minneapolis, Minn).
Statistics
Continuous data are presented as the mean  SEM or median and
interquartile range (25th and 75th percentiles), and categorical data
The Journal of Thoraciare presented as counts and percentages. Between-group compar-
isons were made by using the Wilcoxon rank sum test, a nonpara-
metric equivalent to the standard 2-sample t test, for continuous-
type data, and Fisher exact tests were used for categorical-type
data. All analyses were performed with SAS for Windows soft-
ware version 8.0 (SAS Institute, Cary, NC).
Results
Effect of Chronic Aspiration on the Gross Pathology
of Pulmonary Grafts
Nineteen allotransplantations were performed by using grafts
of WKY donor origin in F344 recipients. Seven (37%) of
these recipients received directed intratracheal gastric fluid
instillation as described in “Materials and Methods.” Ten
isotransplantations (F344 to F344) were performed in a
similar fashion; 4 (40%) of these animals received directed
intratracheal gastric fluid instillation. Thus, 12 allotrans-
plantation cases and 6 isotransplantation cases were not
administered gastric contents and served as control groups
(Table 1). Upon termination of the experiment, 8 (67%) of
12 of the allotransplant recipients without aspiration had
functional grafts according to gross examination of perfu-
sion, mechanical ventilation, color, and size (Figure 1, in-
set). In contrast, all 7 allograft recipients receiving gastric
fluid aspiration demonstrated diminutive, noncompliant,
and discolored grafts without normal perfusion (Fisher ex-
act test; P  .013). Consistent with the idea that organ
dysfunction was associated with an allospecific response,
isografts in the face of aspiration seemed functional at the
termination of the experiment.
Effect of Chronic Aspiration on the Histologic
Appearance of Pulmonary Grafts
Representative histologic characteristics of pulmonary grafts
from the 4 groups of recipients are depicted in Figure 2.
Allotransplant recipients receiving no aspiration developed
TABLE 1. Description of lung transplant groups
Experimental groups* No. subjects
5-wk isotransplantation† 6
5-wk isotransplantation with aspiration 4
5-wk allotransplantation‡ 6
5-wk allotransplantation with aspiration 4
9-wk allotransplantation 6
9-wk allotransplantation with aspiration 3§
All allotransplantations (5- and 9-wk groups) 12
All allotransplantations (5- and 9-wk groups)
with aspiration
7
*Time given indicates how many weeks after transplantation that the
recipient was killed. †Isotransplantations involved strains F344 to F344.
‡Allotransplantations involved strains WKY to F344. §One recipient from
the 9-week allotransplantation with aspiration was lost secondary to a
technical complication during an episode of aspirate instillation.moderate interstitial mononuclear cell infiltrates with mod-
c and Cardiovascular Surgery ● Volume 131, Number 1 211
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tained relatively normal lung architecture. Conversely, pul-
monary allografts exposed to chronic aspiration demon-
strated considerably worse histologic injury, with extensive
interstitial and alveolar infiltration of mononuclear cells
(grade A4). These recipients also exhibited diffuse destruc-
tion of alveolar and interstitial structure. Microscopic ex-
amination of isotransplant grafts with or without aspiration
Figure 2. Effect of chronic aspiration on the histologic
procured from rats receiving isografts (A and B) or allo
fluid aspiration. Tissues were fixed, processed, and sta
Figure 1. Effect of chronic aspiration on isograft and all
receiving pulmonary isografts or allografts with or wit
compilation of 5- and 9-week allotransplantation resu
gastric fluid were functioning at the termination of the
Fisher exact tests. Allo or AlloTx, Allotransplant; Iso,and Methods.”
212 The Journal of Thoracic and Cardiovascular Surgery ● Janudid not reveal acute rejection or abnormal parenchymal
architecture.
Control allografts lacking aspiration demonstrated mod-
erate amounts of interstitial fibrosis, with a median fibrotic
grade of 1.63 (interquartile range, 1.46-5.20; Figure 3, in-
set). However, the allografts receiving aspiration revealed a
more severe fibrotic pattern, with a median fibrotic grade of
6.33 (interquartile range, 3.75-8.00; P  .016; Figure 3).
acteristics of isografts and allografts. Lung tissue was
s (C and D) with (B and D) or without (A and C) gastric
with hematoxylin and eosin as described in “Materials
t survival. The percentage of functioning organs in rats
gastric fluid aspiration is shown. The inset provides a
one of the allotransplant organs receiving aspirated
eriment. Statistical comparisons were performed with
nsplant; Asp, with aspiration.char
graft
inedograf
hout
lts. N
exp
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brotic grade, 1.55; interquartile range, 1.05-3.14) had less
fibrosis than the 9-week allotransplants (median fibrotic
grade, 3.85; interquartile range, 1.04-6.37; P  .24). How-
ever, with aspiration, the 5-week allotransplants (median
fibrotic grade, 5.65; range, 3.71-8.00) had levels of fibrosis
similar to those of the 9-week allotransplants (median fi-
brotic grade, 6.33; range, 2.00-8.00; P  .86). Overall,
control isografts and isografts from recipients with aspira-
tion appeared normal, without significant fibrosis (Figure 3).
Cellular Infiltrates in Response to Chronic Aspiration
in Pulmonary Grafts
As described previously, substantial mononuclear cell infil-
trates were observed in allografts but not in isografts. Al-
though mononuclear infiltrates were observed in the allo-
grafts of animals with gastric fluid aspiration and in those
with no aspiration, the infiltrates were more pronounced in
those with gastric fluid aspiration. Consistent with these
observations, isografts demonstrated minimal numbers of
CD68 or CD8 cells by immunohistochemical analysis,
Figure 3. Effect of chronic aspiration on fibrosis in isog
receiving isografts or allografts with or without gastric
with Masson trichrome stain as described in “Material
as described in “Materials and Methods” and was com
The inset provides a compilation of 5- and 9-week allo
isotransplant; Asp, with aspiration.regardless of the presence or absence of aspiration (Figure 4).
The Journal of ThoraciConversely, immunohistochemical analysis revealed signif-
icant CD68 and CD8 cellular infiltrates in allografts; the
most severe infiltration by CD68 and CD8 cells occurred
in allografts with aspiration. CD68 and CD8 cells in the
allografts with aspiration were present diffusely, throughout
the alveolar spaces and interstitium, and their presence did
not seem to correlate with areas of perivascular infiltration
or cuffing.
Serum Cytokines
Figure 5 shows the serum levels of TGF- in the different
transplantation groups at the termination of the experiment.
Whereas control allografts without aspiration had levels of
TGF- similar to those in isografts, regardless of how long
after transplantation they were, allografts with aspiration
had significantly higher levels of TGF- (Figure 5; P 
.026). Similarly, the isografts with aspiration also had greater
serum concentrations of TGF- than control isografts; how-
ever, this difference did not reach statistical difference (Fig-
ure 5; P  .34). Serum concentrations of IL-4 were not
and in allografts. Lung tissue was procured from rats
aspiration. Tissues were fixed, processed, and stained
 Methods.” The fibrosis score shown was determined
between groups by using the Wilcoxon rank sum test.
splantation results. Allo or AlloTx, Allotransplant; Iso,rafts
fluid
s and
pared
trandetectable in any of the groups, whereas IL-2, IL-6, IL-10,
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did not differ significantly in the allotransplantation animals
secondary to the administration of gastric fluid (data not
shown).
Discussion
Several groups have emphasized the role that nonimmune
injury may have in accelerating pulmonary allograft dys-
function. Possible nonimmune insults include cytomegalo-
virus pneumonitis, viral infection, ischemia-reperfusion in-
jury, and GERD.4,5,12,23,24 Previous clinical studies by our
group supported a relationship between GERD and prema-
ture chronic graft dysfunction.12 Initial case reports sug-
gested that microaspiration events secondary to excessive
GERD may be contributing to graft failure.25 After this, our
group reported impaired pulmonary function in lung recip-
ients with GERD that could be improved with a surgical
corrective procedure for GERD (ie, fundoplication).12,14
Reviews of our lung transplant database also suggested an
association between GERD and more severe acute rejection
that may be ameliorated with fundoplication.13 This study
describes a novel animal model for chronic aspiration in a
rodent pulmonary transplant system that was designed to
study the cellular and molecular mechanisms underlying
accelerated graft dysfunction secondary to aspiration of
enteric contents.
Early animal models of acute lung injury secondary to
aspiration, or Mendelson syndrome, demonstrated that a pH
of less than 2.5 was critical for promoting lung injury.26
Using a swine model of aspiration, others showed that
pepsin also significantly contributed to pulmonary injury
Figure 4. Immunohistochemical analysis of cellular in
chronic aspiration. Lung tissue was procured from rats
H) with (B, D, F, and H) or without (A, C, E, and G) gas
(A-D) or CD8 (E-H) as described in “Materials and Meand that instillation of large, potentially lethal quantities of
214 The Journal of Thoracic and Cardiovascular Surgery ● Janugastric fluid led to significant alterations in pulmonary phys-
iology and subsequent pulmonary fibrosis.27 Although im-
portant, the aforementioned studies do not address the role
of GERD in lung transplantation for multiple reasons. First,
the earlier studies focused on a single large-volume aspira-
tion event. However, in lung recipients, GERD-induced
injury is likely secondary to repetitive smaller aspiration
events that may not create overt symptoms or aberrant
physiology. Although this has not been demonstrably proven
in human lung recipients, preliminary data show high levels of
pepsin and bile acids in bronchoalveolar lavage samples of
lung recipients without a history of known aspiration
events.15,16 This study is the first to describe the effects of
smaller, repetitive, and nonlethal doses of gastric contents
aspirated into a pulmonary isograft or allograft.
Data demonstrating that aspiration leads to accelerated
loss of graft function corroborate findings from retrospec-
tive reviews of human clinical data. In this study, all of the
allografts that received aspirated gastric contents were non-
functioning by the end of the study, compared with only
33% of the control allografts. This significant difference in
graft function seems to involve allospecific, immune-mediated
lung injury, because aspiration had no such effect on
isografts. In addition, the survival of isografts in the face of
aspiration eliminates technical failure as a potential cause
for the loss of allograft function. Consistent with the con-
clusion that allospecific immune reactions are involved in
the aspiration-associated allograft failure we observed is the
observation that early works in aspiration injury demon-
strated deleterious physiologic effects from low pH and
pepsin, but not lung failure.26,27 Likewise, our model of
tes in isografts and allografts, both with and without
iving isografts (A, B, E, and F) or allografts (C, D, G, and
fluid aspiration. Tissues were stained for either CD68
s.”filtra
rece
tric
thodchronic aspiration, when performed for up to 4 months in
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TXnontransplant rats, did not lead to overt pulmonary failure in
any of the animals (J.Z.A. and M.G.H., unpublished data).
Therefore, some level of baseline alloimmune injury seems
to play an important role in aspiration-induced loss of graft
function.
OB is thought to develop secondary to alloimmune injury
that manifests clinically as acute rejection.28 Acute rejection is
believed to occur as a result of antigen-presenting cells
(APCs) processing and presenting donor antigen to host T
lymphocytes. APCs are responsible for initiating and prop-
agating acute rejection, whereas graft-infiltrating lympho-
cytes mediate the rejection response. This study demon-
strates an increase in graft infiltration by macrophages and
CD8 lymphocytes as a result of aspiration. These results
are consistent with a predilection for acute rejection as a
result of aspiration. Alveolar macrophages are important
sources of chemotactic agents for lymphocytes during re-
jection, and depleting those macrophages downregulates
chemotaxis for lymphocytes.29 Likewise, increases in CD8
cells correlate with the progression of acute rejection in a
model of rat transplantation.30 Taken together, these results
suggest that aspiration of gastric contents leads to an in-
Figure 5. Effect of chronic aspiration on the levels of T
level of TGF- in the serum of rats receiving isografts or
The inset provides a compilation of 5- and 9-week allo
made by using an unpaired 2-tailed t test. Allo or AlloTcreased potential for antigen presentation secondary to in-
The Journal of Thoracicreases in graft APCs, as well as increased rejection injury
as a result of more graft-infiltrating lymphocytes.
TGF- is a potent profibrotic cytokine with a multifac-
eted role in lung transplantation. Recently, reports suggest
that TGF- may play an important role in the pathogenesis
of OB. Elssner and colleagues31 demonstrated increased
levels of TGF- in epithelial lining fluid and in the bron-
choalveolar lavage fluid cells of patients with BOS. In a
murine heterotopic tracheal model of OB, expression of
TGF- was increased in obliterated grafts compared with
unaffected isografts.32 Additionally, immunohistochemistry
analysis of biopsy samples from human lung recipients
demonstrated greater TGF- expression in patients with OB
than in those without OB.33 Finally, inhibition of TGF-
intracellular signaling pathways in tracheal allografts de-
creased intraluminal deposition of fibrous material.34 The
current study is consistent with previous research in that it
associates TGF- with pulmonary allograft fibrosis. This
study suggests that one pathway for aspiration-induced lung
injury may be via promoting a profibrotic cytokine milieu
that, when combined with a host alloimmune response,
leads to accelerated graft failure. It also demonstrates that
 in the serum of isograft and allograft recipients. The
grafts with or without gastric fluid aspiration is shown.
plantation results. Comparisons between groups were
lotransplant; Iso, isotransplant; Asp, with aspiration.GF-
allo
trans
x, Alchronic aspiration is capable of increasing systemic TGF-
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tissue.
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Discussion
Dr Raphael Bueno (Boston, Mass). In this elegant study, you
propose and evaluate a new animal model to study the effect of
reflux in lung grafts in rats. You compared the effect of injecting
gastric contents into lung allograft versus lung isograft, showing
more rapid progression of fibrosis in allografts receiving acid. You
conclude that aspirated gastric secretions enhance acute rejection
type injuries, which would likely eventually lead to chronic rejec-
tion. Certainly we have heard from your group over the years how
this is relevant in lung transplantation.
I have several brief questions. First, you used a 0.5 cc/kg
injection transtracheally of reflux material once a week. How did
you come up with that dose? Did you do dose-response tests? If
you translate it to humans, that’s 35 cc’s for the 70-kg person, and
that’s a lot.
Dr Hartwig. That is correct. What we did was a combination
of literature search and our own informal LD50 [median lethal
ary 2006
Hartwig et al Cardiothoracic Transplantationdose] experiments essentially. If you look at some of the earlier
work in aspiration injury, also referred to as Mendelson syndrome,
you will note that it’s usually a 1-time instillation of acid and it’s
usually a very, very large dose, 10 to 20 times what we were using,
and occasionally they would see death of the animals subsequent
to that. We knew we wanted to be below any sort of lethal level,
so we performed our own informal LD50 experiments and deter-
mined that we would be well below that, probably about a tenth of
that dose. I don’t know if you can directly correlate rats and
humans as far as lung volume and instillation of volumes. If you
did a milliliter per kilogram for a human, it would be much
more than you would expect on a microaspiration level, but,
again, since this was sort of a novel model, we wanted to make
sure that we were giving enough to see an injury response pattern
in the time frames and time constraints that we had for the
experiment while making sure we stayed well below any sort of
lethal dose, and we did not experience any lethal events during the
injection of the acid.
Dr Bueno. Certainly in humans we give immunosuppression
after transplantation. Have you tried or are you proposing to try
adding immunosuppression in the allograft group to see how that
will influence the progression of disease?
Dr Hartwig. Absolutely. I think that’s probably the primary
limiting factor of this study. Our baseline rejection injury in theThe Journal of Thoracihoped and thought originally. So I think it’s going to be very
important to not only minimize that baseline injury from the
standpoint of injury without aspiration, but then in order to be able
to extend the experiment out more months and better recreate what
we see clinically, the next step is going to be immunosuppression
of the animals. Those projects are in process. Unfortunately, we
would like to take them out 2, 3, or 4 months to better characterize
that. It takes time to do those experiments.
Dr Bueno. And, finally, you were very careful in the types of
rats you transplanted and treated, but in the manuscript you made
available to me, you just collected the gastric secretions from
rodents. You didn’t specify the type. We’re dealing with poten-
tially immunologic injuries that you are suggesting or proposing
based on the mononuclear infiltrates, et cetera. Do you think that
the source of protein—whether it is from the same rat type or a
different rat type—that comes from the stomach has any effect on
what happens, or is it just an initial chemical reaction?
Dr Hartwig. Right. That’s a wonderful question. When we first
started this work, it’s not something that we had planned for
originally, and so we were arbitrarily using gastric fluid from either
WKY or F344 rats. However, for the next set of experiments, what
we did prospectively was collect gastric fluid only from the F344
rodents and collected it all in advance, pooled it, and kept it
together, so that there will be homogeneous gastric fluid in the nextTXnon-aspirating animals was significant, much more so than we had set of experiments.c and Cardiovascular Surgery ● Volume 131, Number 1 217
